Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1

Interventions

pembrolizumab 65 Nivolumab 58 Ipilimumab 32 Cyclophosphamide 22 Specimen Handling 16 Magnetic Resonance Spectroscopy 15 Biopsy 15 relatlimab 13 cemiplimab 13 fludarabine 12 Opdualag 12 binimetinib 10 Blood Specimen Collection 10 aldesleukin 9 Radiosurgery 9 encorafenib 8 Interleukin-2 8 atezolizumab 7 Immunotherapy 7 tebentafusp 6 mogamulizumab 6 fludarabine phosphate 6 Temozolomide 6 Surgical Procedures, Operative 6 Paclitaxel 6 Immunoglobulin G 6 CTLA-4 Antigen 6 Radiotherapy 5 Disulfides 5 Bevacizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × green tea extract polyphenone E × Dermatologic × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡